S

Sagimet Biosciences (SGMT)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Sagimet Biosciences (SGMT)

Sagimet Biosciences Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a portfolio of internally-discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of several diseases that result from ... Read more

Open
USD7.95
High
USD8.36
Low
USD7.80
52 Week High
USD10.43
Monthly Return
127.30%
Revenue
--

Daily Vol.
556.04k
Avg. Daily Vol.
2.54M
Market Cap.
241M
52 Week Low
1.73
Annual Return
189.50%

Stock News

Revolution Medicines, Summit Therapeutics Partner on RAS Inhibitor/Ivonescimab Combinations for Solid Tumors

Revolution Medicines, Summit Therapeutics Partner on RAS Inhibitor/Ivonescimab Combinations for Solid Tumors

Yahoo

Arista Networks' Nvidia Problem And The Solution

Arista Networks' Nvidia Problem And The Solution

SeekingAlpha

I've Been Selling AI Stocks In The Name Of Value, But I Kept Tesla

I've Been Selling AI Stocks In The Name Of Value, But I Kept Tesla

SeekingAlpha

O'Reilly Automotive: Future Growth Is Priced In Already

O'Reilly Automotive: Future Growth Is Priced In Already

SeekingAlpha

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.